UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up

Journal of human hypertension, 2017-12, Vol.31 (12), p.826-830

2017

Volltextzugriff (PDF)

CLINICAL VALIDATION OF THE NEW AUTOMATED ALDOSTERONE LIAISON XL ASSAY ON THE ADRENAL VEIN SAMPLING CONFIRMATORY TEST

Journal of hypertension, 2019-07, Vol.37, p.e220

2019

Volltextzugriff (PDF)

URINARY EXOSOMAL MRNA ANALYSIS OF NCC IN PRIMARY ALDOSTERONISM

Journal of hypertension, 2019-07, Vol.37, p.e225

2019

Volltextzugriff (PDF)

Investigation of a Bridge Mechanical Response by a Joint Innovative Impulsive Energizer and a Wavelet Analysis

International Journal of Civil Engineering, 2021-09, Vol.19 (9), p.997-1006

2021

Volltextzugriff (PDF)

Apolipoprotein C‐III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation

Journal of thrombosis and haemostasis, 2010-03, Vol.8 (3), p.463-471

2010

Volltextzugriff (PDF)

[OP.3A.04] ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM: A SIX-CENTER EXPERIENCE

Journal of hypertension, 2016-09, Vol.34 Suppl 2 - ESH 2016 Abstract Book (Supplement 2), p.e27-e27

2016

Volltextzugriff (PDF)

C0401: Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele

Thrombosis research, 2014-05, Vol.133, p.S82-S82

2014

Volltextzugriff (PDF)

Laboratory Diagnosis of Primary Aldosteronism, and Drospirenone-Ethinylestradiol Therapy

American journal of hypertension, 2007-12, Vol.20 (12), p.1334-1337

2007

Volltextzugriff (PDF)

[LB.01.32] URINARY METABOLIC SIGNATURE OF PRIMARY ALDOSTERONISM: GENDER AND SUBTYPE SPECIFIC ALTERATIONS

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e168-e169

2017

Volltextzugriff (PDF)

PREVALENCE AND CLINICAL FEATURES OF INCREASED URINARY STEROID RATIO OF CORTISOL TO CORTISONE METABOLITES (THF+ATHF)/THE IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PRIMARY HYPERALDOSTERONISM

Journal of hypertension, 2018-06, Vol.36 (Supplement 1), p.e209

2018

Volltextzugriff (PDF)

Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage

Journal of human hypertension, 2007-04, Vol.21 (4), p.327-329

2007

Volltextzugriff (PDF)

[PP.27.02] PERFORMANCE OF FULLY AUTOMATED CHEMILUMINESCENCE ALDOSTERONE IMMUNOASSAY IN A POPULATION OF HYPERTENSIVE PATIENTS

Journal of hypertension, 2017-09, Vol.35 (Supplement 2), p.e312

2017

Volltextzugriff (PDF)

Prevalence of body iron excess in the metabolic syndrome

Diabetes care, 2005-08, Vol.28 (8), p.2061-2063

2005

Volltextzugriff (PDF)

Homocysteine, traditional risk factors and impaired renal function in coronary artery disease

European journal of clinical investigation, 2006-10, Vol.36 (10), p.698-704

2006

Volltextzugriff (PDF)

PP.09.28: INCREASED URINARY RELEASE OF ENAC-ACTIVATING PROSTASIN IN PATIENTS AFFECTED BY PRIMARY ALDOSTERONISM

Journal of hypertension, 2015-06, Vol.33 (Supplement 1), p.e216

2015

Volltextzugriff (PDF)

Aldosterone to Renin Ratio in a Primary Care Setting: The Bussolengo Study

The journal of clinical endocrinology and metabolism, 2004-09, Vol.89 (9), p.4221-4226

2004

Volltextzugriff (PDF)

PB0713 Increased Tissue Factor mRNA Expression is Associated with High Plasma Levels of Activated Factor VII-Antithrombin Complex and Predicts Mortality in Primary Liver Cancer

Research and practice in thrombosis and haemostasis, 2023-10, Vol.7, p.101301, Article 101301

2023

Volltextzugriff (PDF)

Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk

The American journal of clinical nutrition, 2004-06, Vol.79 (6), p.992-998

2004

Volltextzugriff (PDF)

Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease

Clinical and experimental medicine, 2005-05, Vol.5 (1), p.20-30

2005

Volltextzugriff (PDF)

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Journal of lipid research, 2003-12, Vol.44 (12), p.2374-2381

2003

Volltextzugriff (PDF)

Extensive life-threatening thrombosis in a patient with heparin-induced thrombocytopenia and factor V Leiden mutation

Haematologica (Roma), 2001-09, Vol.86 (9), p.1008

2001

Volltextzugriff (PDF)

Urinary Prostasin: A Candidate Marker of Epithelial Sodium Channel Activation in Humans

Hypertension (Dallas, Tex. 1979), 2005-10, Vol.46 (4), p.683-688

2005

Volltextzugriff (PDF)

Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction

European journal of clinical investigation, 2004-01, Vol.34 (1), p.14-20

2004

Volltextzugriff (PDF)

URINARY PROSTASIN, A SERIN- PROTEASE ACTIVATING ENAC, IS PHYSIOLOGICALLY MODULATED BY NATRIURESIS IN NORMOTENSIVE INDIVIDUALS: PP.39.274

Journal of hypertension, 2011-06, Vol.29, p.e512

2011

Volltextzugriff (PDF)

Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and "Insulin-Resistant" T-455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction

Clinical chemistry (Baltimore, Md.), 2005-02, Vol.51 (2), p.360-367

2005

Volltextzugriff (PDF)

1 – 25 von 279

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(259)
Mit Volltextzugriff
(210)

Publikationsform

Sprache

Englisch
(276)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

Humans
(204)
Science & Technology
(184)
Life Sciences & Biomedicine
(183)
Biological And Medical Sciences
(128)
Male
(121)
Medical Sciences
(121)
Female
(119)
Middle Aged
(104)
Adult
(102)
Hematology
(80)
Hematologic And Hematopoietic Diseases
(78)
Aged
(74)
Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis
(67)
Oncology
(46)
Adolescent
(40)
Prognosis
(25)
Immunology
(24)
Child
(19)
Immunohistochemistry
(19)
Flow Cytometry
(18)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Blood
(34)
Haematologica
(25)
British Journal Of Haematology
(19)
Leukemia
(15)
Cancer
(14)
Journal Of Hypertension
(13)
The American Journal Of Pathology
(6)
British Journal Of Cancer
(5)
Clinical And Experimental Immunology
(5)
Clinical And Experimental Medicine
(5)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Fully automated chemiluminescence vs RIA aldosterone assay in primary aldosteronism work-up

CLINICAL VALIDATION OF THE NEW AUTOMATED ALDOSTERONE LIAISON XL ASSAY ON THE ADRENAL VEIN SAMPLING CONFIRMATORY TEST

URINARY EXOSOMAL MRNA ANALYSIS OF NCC IN PRIMARY ALDOSTERONISM

Investigation of a Bridge Mechanical Response by a Joint Innovative Impulsive Energizer and a Wavelet Analysis

Apolipoprotein C‐III predicts cardiovascular mortality in severe coronary artery disease and is associated with an enhanced plasma thrombin generation

[OP.3A.04] ADRENAL HEMORRHAGE FOLLOWING ADRENAL VEIN SAMPLING IN PRIMARY ALDOSTERONISM: A SIX-CENTER EXPERIENCE

C0401: Factor II Activity is Similarly Increased in Patients with Elevated Apolipoprotein CIII and in Carriers of the Factor II 20210A Allele

Laboratory Diagnosis of Primary Aldosteronism, and Drospirenone-Ethinylestradiol Therapy

[LB.01.32] URINARY METABOLIC SIGNATURE OF PRIMARY ALDOSTERONISM: GENDER AND SUBTYPE SPECIFIC ALTERATIONS

PREVALENCE AND CLINICAL FEATURES OF INCREASED URINARY STEROID RATIO OF CORTISOL TO CORTISONE METABOLITES (THF+ATHF)/THE IN PATIENTS WITH ESSENTIAL HYPERTENSION AND PRIMARY HYPERALDOSTERONISM

Altered renal folate handling in hypertensive patients with nephroangiosclerotic damage

[PP.27.02] PERFORMANCE OF FULLY AUTOMATED CHEMILUMINESCENCE ALDOSTERONE IMMUNOASSAY IN A POPULATION OF HYPERTENSIVE PATIENTS

Prevalence of body iron excess in the metabolic syndrome

Homocysteine, traditional risk factors and impaired renal function in coronary artery disease

PP.09.28: INCREASED URINARY RELEASE OF ENAC-ACTIVATING PROSTASIN IN PATIENTS AFFECTED BY PRIMARY ALDOSTERONISM

Aldosterone to Renin Ratio in a Primary Care Setting: The Bussolengo Study

PB0713 Increased Tissue Factor mRNA Expression is Associated with High Plasma Levels of Activated Factor VII-Antithrombin Complex and Predicts Mortality in Primary Liver Cancer

Low plasma vitamin B-6 concentrations and modulation of coronary artery disease risk

Interaction between metabolic syndrome and PON1 polymorphisms as a determinant of the risk of coronary artery disease

Apolipoprotein C-III, metabolic syndrome, and risk of coronary artery disease

Extensive life-threatening thrombosis in a patient with heparin-induced thrombocytopenia and factor V Leiden mutation

Urinary Prostasin: A Candidate Marker of Epithelial Sodium Channel Activation in Humans

Interaction between smoking and PON2 Ser311Cys polymorphism as a determinant of the risk of myocardial infarction

URINARY PROSTASIN, A SERIN- PROTEASE ACTIVATING ENAC, IS PHYSIOLOGICALLY MODULATED BY NATRIURESIS IN NORMOTENSIVE INDIVIDUALS: PP.39.274

Apolipoprotein C-III, n-3 Polyunsaturated Fatty Acids, and "Insulin-Resistant" T-455C APOC3 Gene Polymorphism in Heart Disease Patients: Example of Gene-Diet Interaction

Suchergebnisse filtern